Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

288
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
288
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

454
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
454
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

1.4K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
1.4K
Dialysis01:27

Dialysis

1.0K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.0K
Dialysis01:15

Dialysis

1.4K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.4K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

215
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Spine Society: 25th Annual Scientific Conference, February 25 to 28, 2025, Fairmont Le Manoir Richelieu, La Malbaie, Charlevoix, Que., Canada.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

Sex-Specific Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Trends and contributing factors in medicolegal cases involving cranial surgery in Canada.

Journal of neurosurgery·2025
Same author

The Tailored Biosimilar Approach: Expectations and Requirements.

Drugs·2025
Same author

Effect of Steroids on the Progression of Alzheimer's Dementia: A Retrospective Chart Review.

Aging medicine (Milton (N.S.W))·2025
Same author

Editorial for focus on emerging processes and applications of atomic and molecular layer deposition.

Nanotechnology·2024

Related Experiment Video

Updated: Dec 13, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K

Evaluating Factors Contributing to Dropout in a Large Peritoneal Dialysis Program.

Hayden Torres1, Mihran Naljayan1, Maria Frontini2

  • 1Louisiana State University Health Sciences Center in New Orleans - Section of Nephrology and Hypertension, School of Medicine, New Orleans, Louisiana.

The American Journal of the Medical Sciences
|August 1, 2020
PubMed
Summary

Psychosocial factors (PF) are the main reason patients leave peritoneal dialysis (PD). Addressing PF is key to improving PD therapy retention and prevalence.

Keywords:
Dialysis dropoutEnd stage renal diseasePeritoneal dialysis

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.8K
A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

2.1K

Related Experiment Videos

Last Updated: Dec 13, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.8K
A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

2.1K

Area of Science:

  • Nephrology
  • Dialysis Therapy
  • Patient Retention Studies

Background:

  • Peritoneal dialysis (PD) has low prevalence (9%) compared to hemodialysis (HD) (88.2%).
  • Patient dropout is a significant factor contributing to the low prevalence of PD.

Purpose of the Study:

  • To identify the primary reasons for patient withdrawal from peritoneal dialysis.
  • To analyze controllable factors influencing PD therapy dropout.

Main Methods:

  • Retrospective study of patients withdrawing from PD between 2016-2018.
  • Evaluation of dropout reasons, time on therapy, and method of initiation.
  • Analysis of psychosocial factors (PF) as a controllable loss.

Main Results:

  • 27 out of 83 patients dropped out; 24 due to controllable factors.
  • Psychosocial factors (PF) were the largest controllable factor, causing 63% of controllable dropouts.
  • PF influenced dropout across all time points and initiation methods.

Conclusions:

  • Psychosocial factors are the primary driver of controllable patient loss from PD therapy.
  • Interventions targeting PF are crucial for improving PD patient retention.